32
Participants
Start Date
April 27, 2005
Primary Completion Date
July 28, 2006
Study Completion Date
July 14, 2008
Prochymal® - 2 Million cells/kg
2 million hMSCs/kg actual body weight, IV on study Days 1 and 4
Prochymal®- 8 Million cells/kg
8 million hMSCs/kg actual body weight IV on study Days 1 and 4
Methylprednisolone
Methylprednisolone 2 mg/kg administered intravenously.
Prednisone
Prednisone 2.5 mg/kg administered orally.
Cyclosporine
Administered as prescribed by the caregiver.
Tacrolimus
Administered as prescribed by the caregiver.
Mycophenolate Mofetil
Administered as prescribed by the caregiver.
Mt. Sinai Hospital, New York
New York Medical College, Valhalla
Roswell Park Cancer Institute, Buffalo
University of Rochester, Rochester
St. Francis Hospital, Indianapolis
Medical College of Wisconsin, FEC, Milwaukee
Kansas City Cancer Centers - BMT, Kansas City
MD Anderson Cancer Center, Houston
The Cancer Center at Hackensack University, Hackensack
Lead Sponsor
Mesoblast, Inc.
INDUSTRY